ICR calls for improved biomarker cancer tests to help personalise treatment - PMLiVE
Cancer: Scientists aim to double survival within a decade | The Independent
The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined
Professor Kevin Harrington - YouTube
Using imaging to predict and improve responses to immunotherapy - Oracle Cancer Trust
ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - The Institute of Cancer Research, London
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden
SAB and I-O AB - T3 Pharma
Oracle Research Event 2019 Kevin Harrington: Radiotherapy - YouTube
Cancer survival 'to double in 10 years' - PressReader
Professor Kevin Harrington - The Institute of Cancer Research, London
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
The Institute of Cancer Research - Professor Kevin Harrington (ICR + Royal Marsden NHS Foundation Trust) responds to today's news of the 2018 Nobel Prize for Physiology or Medicine being awarded to
.jpg?sfvrsn=a729a68_4 "Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London")
Tumour assassination – using smart targeted treatments to enhance anti-cancer radiation responses - The Institute of Cancer Research, London
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London
Histological and functional studies of isolated arteries containing contrast agents exposed to high intensity focused ultrasoun
Professor Kevin Harrington - The Institute of Cancer Research, London
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
_kevin-harrington-embed.jpg?sfvrsn=70547b69_2 "Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London")
Radiotherapy supercharges cancer-targeting viruses to treat deadly skin cancer - The Institute of Cancer Research, London
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London
